Clinical Trial Update: -Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans. [NA]

View source ↗

Summary

A completed clinical trial indicates that oleoyl glycerol acts as a GPR119 agonist and stimulates GLP-1 release in humans, studied in Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Oleoyl Glycerol (oleoyl glycerol)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Type 2 Diabetes | NA | Status: COMPLETED